Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,571 Blood Cancer
clinical trials

Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
William Beaumont Hospital-Grosse Point
mi
from
Grosse Pointe, MI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
mi
from
Maumee, OH
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Franciscan Saint Anthony Health-Michigan City
mi
from
Michigan City, IN
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Health Mercy Campus
mi
from
Muskegon, MI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KS
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
UC Irvine Health/Chao Family Comprehensive Cancer Center
mi
from
Orange, CA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Radiation Oncology of Northern Illinois
mi
from
Ottawa, IL
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Peru
mi
from
Peru, IL
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KS
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Spectrum Health Reed City Hospital
mi
from
Reed City, MI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Marie Yeager Cancer Center
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Sainte Genevieve County Memorial Hospital
mi
from
Sainte Genevieve, MO
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Illinois Hematology Oncology Center
mi
from
Springfield, IL
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Saint Anne Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Munson Medical Center
mi
from
Traverse City, MI
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia ALLLymphoblastic Lymphoma LBL Clinical Trial
An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)
Status: Enrolling, Phase II
Updated: 3/3/2015
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia ALLLymphoblastic Lymphoma LBL Clinical Trial
An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)
Status: Enrolling, Phase II
Updated: 3/3/2015
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
SUNY- Stony Brook Medical Oncology SC
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute SC - 5
mi
from
Tampa, FL
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
Status: Enrolling
Updated: 12/31/1969
University of Iowa - Holden Comprehensive Cancer Center
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
Mission Hospital-Memorial Campus
mi
from
Asheville, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
Steven & Alexandra Cohen Children's Medical Center of New York
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwestern University Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling, Phase III
Updated: 12/31/1969
City of Hope Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling, Phase III
Updated: 12/31/1969
Indiana University
mi
from
Goshen, IN
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling, Phase III
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Georgia Oncology Centers, PC
mi
from
Marietta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling, Phase III
Updated: 12/31/1969
Kansas University Medical Center
mi
from
Westwood, KS
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas
Status: Enrolling, Phase I, II
Updated: 4/28/2015
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Status: Enrolling
Updated: 12/31/1969
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Click here to add this to my saved trials
Hematologic Malignancies Clinical Trial
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation
Status: Enrolling, Phase II
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Safety Study of MGD006 in Relapsed/Refractory Acute Myeloid Leukemia (AML) or Intermediate-2/High Risk MDS
Status: Enrolling, Phase I
Updated: 9/12/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Status: Enrolling, Phase I
Updated: 6/22/2016
Texas Oncology - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institute
mi
from
Amarillo, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institute
mi
from
Canton, OH
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institution
mi
from
Corona, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institution
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institute
mi
from
Knoxville, TN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institution
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institute
mi
from
Missoula, MT
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institute
mi
from
Yakima, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Acute Myelogenous Leukemia Clinical Trial
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
Status: Enrolling
Updated: 12/31/1969
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
Status: Enrolling, Phase II
Updated: 12/31/1969
Loyola University, Cardinal Bernardin Cancer Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate
Status: Enrolling
Updated: 11/2/2015
Children's Oncology Group
mi
from
Arcadia, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Role of Osteocytes in Myeloma Bone Disease
Status: Enrolling, Phase
Updated: 12/31/1969
VA Roudebush Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
Status: Enrolling, Phase I, II
Updated: 6/7/2016
Lucile Packard Children's Hospital Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Intra-Osseous Co-Transplant of UCB and hMSC
Status: Enrolling, Phase
Updated: 12/31/1969
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Arkansas for Medical Science
mi
from
Little Rock, AR
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma
Status: Enrolling, Phase I
Updated: 11/22/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma
Status: Enrolling, Phase I
Updated: 11/22/2016
University of Pennsylvania - Perelman Center for Advanced Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma
Status: Enrolling, Phase I
Updated: 11/22/2016
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Columbia University Medical Centre
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
St. Louis Cancer Care, LLP
mi
from
Bridgeton, MO
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
New York Presbyterian Hospital Weill Cornell
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
Northern Utah Associates
mi
from
Ogden, UT
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Dell Children's Medical Center of Central Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Blank Children's Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Golisano Children's Hospital of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Children's Cancer and Hematology Centers
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Hematopoietic Stem Cell Transplantation Clinical Trial
A Pharmacokinetic Study of Melphalan in Children
Status: Enrolling, Phase I
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Duke Cancer Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Greenville Health System
mi
from
Greenville, SC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry, Reproductive Clinical Trial
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
Status: Enrolling, Phase II
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies
Status: Enrolling, Phase I
Updated: 3/23/2017
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults
Status: Enrolling, Phase I
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Site US10011
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Site US10047
mi
from
New York, NY
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Site US00068
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Study to Investigate the Safety and Tolerability of REGN1979 in Patients With CD20+ B-Cell Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia (ALL) Clinical Trial
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia (ALL) Clinical Trial
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Children's Medical Center of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia (ALL) Clinical Trial
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Leukemia Clinical Trial
Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive Philadelphia-Chromosome (PC) Positive Acute Lymphoblastic Leukemia (ALL) and Chronic Myeloid Leukemia (CML)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
1 … 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 … 116